# OptiScanner Versus Standard Blood Glucose Monitoring

> **NCT01720381** · — · COMPLETED · sponsor: **OptiScan Biomedical Corporation** · enrollment: 98 (actual)

## Conditions studied

- Hyperglycemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01720381
- **Lead sponsor:** OptiScan Biomedical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2014-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01720381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01720381, "OptiScanner Versus Standard Blood Glucose Monitoring". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01720381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*